Literature DB >> 22143960

HIV in Africa: Challenges and Directions for the Next Decade.

Bruce L Gilliam1, Devang Patel, Rohit Talwani, Zelalem Temesgen.   

Abstract

Africa carries a disproportionate burden of the global HIV endemic, accounting for two thirds of the global 33.3 million people living with HIV. While tremendous advances have been made in addressing the HIV epidemic in Africa, considerable challenges remain. Testing for HIV increased by 86% from 2007 to 2009 but more than 75% of people 15-49 years remain unaware of their HIV status. CD4 count at diagnosis tends to be low and linkage to care and treatment is suboptimal. The scale-up of antiretroviral therapy is ongoing but is hampered by the lack of diagnostic capability to monitor response to therapy and a substantial healthcare workforce shortage. Prevention strategies such as male circumcision, pre-exposure prophylaxis, and antiretroviral therapy for prevention have generated great excitement but cost and healthcare infrastructure deficiencies may limit their widespread applicability. Operational research to validate and inform treatment decisions, health care policies, and prevention strategies is sorely needed.

Entities:  

Year:  2012        PMID: 22143960     DOI: 10.1007/s11908-011-0230-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  82 in total

Review 1.  Economic evaluation of ART in resource-limited countries.

Authors:  Sandrine Loubiere; Constance Meiners; Caroline Sloan; Kenneth A Freedberg; Yazdan Yazdanpanah
Journal:  Curr Opin HIV AIDS       Date:  2010-05       Impact factor: 4.283

Review 2.  Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience.

Authors:  Sylvie Boyer; Sinata Koulla-Shiro; Claude Abé; Bruno Spire; Jean-Paul Moatti
Journal:  Curr Opin HIV AIDS       Date:  2011-07       Impact factor: 4.283

Review 3.  HIV prevention transformed: the new prevention research agenda.

Authors:  Nancy S Padian; Sandra I McCoy; Salim S Abdool Karim; Nina Hasen; Julia Kim; Michael Bartos; Elly Katabira; Stefano M Bertozzi; Bernhard Schwartländer; Myron S Cohen
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

Review 4.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

Review 5.  Challenges in implementing HIV load testing in South Africa.

Authors:  Wendy S Stevens; Theresa M Marshall
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

6.  Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment.

Authors:  Alana T Brennan; Lawrence Long; Mhairi Maskew; Ian Sanne; Imogen Jaffray; Patrick MacPhail; Matthew P Fox
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

7.  Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials.

Authors:  Ravindra Gupta; Andrew Hill; Anthony W Sawyer; Deenan Pillay
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

8.  Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis.

Authors:  Mark D Lindsley; Nanthawan Mekha; Henry C Baggett; Yupha Surinthong; Rinrapas Autthateinchai; Pongpun Sawatwong; Julie R Harris; Benjamin J Park; Tom Chiller; S Arunmozhi Balajee; Natteewan Poonwan
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

9.  Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

Authors:  Andrew Boulle; Catherine Orrel; Richard Kaplan; Gilles Van Cutsem; Matthew McNally; Katherine Hilderbrand; London Myer; Matthias Egger; David Coetzee; Gary Maartens; Robin Wood
Journal:  Antivir Ther       Date:  2007

Review 10.  Treatment of cryptococcal meningitis in resource limited settings.

Authors:  Derek J Sloan; Martin J Dedicoat; David G Lalloo
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915

View more
  5 in total

1.  Comparison of transcriptional profiles between CD4+ and CD8+ T cells in HIV type 1-infected patients.

Authors:  Chaoyu Xu; Baochun Ye; Zongping Han; Mingxing Huang; Yujia Zhu
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09-17       Impact factor: 2.205

2.  Predictors of willingness to accept pre-marital HIV testing and intention to sero-sort marital partners; risks and consequences: Findings from a population-based study in Cameroon.

Authors:  Derick Akompab Akoku; Mbah Abena Tihnje; Elisabeth Oben Tarh; Elvis Enowbeyang Tarkang; Robinson Enow Mbu
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

3.  Mind the gap: Time to address implementation gaps in tuberculosis diagnosis and treatment.

Authors:  Madhukar Pai; Zelalem Temesgen
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-03-02

4.  Accuracy of GenoQuick MTB test in detection of Mycobacterium tuberculosis in sputum from TB presumptive patients in Uganda.

Authors:  Sylvia Kaswabuli; Emmanuel Musisi; Patrick Byanyima; Abdul Sessolo; Ingvar Sanyu; Josephine Zawedde; William Worodria; Laurence Huang; Alfred Okeng; Freddie Bwanga
Journal:  SAGE Open Med       Date:  2022-08-16

5.  PEPFAR Funding and Reduction in HIV Infection Rates in 12 Focus Sub-Saharan African Countries: A Quantitative Analysis.

Authors:  Roger J Chin; Domrongphol Sangmanee; Lisa Piergallini
Journal:  Int J MCH AIDS       Date:  2015
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.